203 related articles for article (PubMed ID: 35322584)
1. Single-Cell RNA-seq Reveals a Developmental Hierarchy Super-Imposed Over Subclonal Evolution in the Cellular Ecosystem of Prostate Cancer.
Ge G; Han Y; Zhang J; Li X; Liu X; Gong Y; Lei Z; Wang J; Zhu W; Xu Y; Peng Y; Deng J; Zhang B; Li X; Zhou L; He H; Ci W
Adv Sci (Weinh); 2022 May; 9(15):e2105530. PubMed ID: 35322584
[TBL] [Abstract][Full Text] [Related]
2. Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.
Fan J; Lee HO; Lee S; Ryu DE; Lee S; Xue C; Kim SJ; Kim K; Barkas N; Park PJ; Park WY; Kharchenko PV
Genome Res; 2018 Aug; 28(8):1217-1227. PubMed ID: 29898899
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
Lai H; Cheng X; Liu Q; Luo W; Liu M; Zhang M; Miao J; Ji Z; Lin GN; Song W; Zhang L; Bo J; Yang G; Wang J; Gao WQ
Int J Cancer; 2021 Dec; 149(12):2099-2115. PubMed ID: 34480339
[TBL] [Abstract][Full Text] [Related]
4. Decomposing the subclonal structure of tumors with two-way mixture models on copy number aberrations.
Tai AS; Peng CH; Peng SC; Hsieh WP
PLoS One; 2018; 13(12):e0206579. PubMed ID: 30540749
[TBL] [Abstract][Full Text] [Related]
5. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J
Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198
[TBL] [Abstract][Full Text] [Related]
7. Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.
Liu D; Augello MA; Grbesa I; Prandi D; Liu Y; Shoag JE; Karnes RJ; Trock BJ; Klein EA; Den RB; Demichelis F; Davicioni E; Sboner A; Barbieri CE
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998599
[TBL] [Abstract][Full Text] [Related]
8. Revealing the subtyping of non-small cell lung cancer based on genomic evolutionary patterns by multi-region sequencing.
Liao G; Liang X; Ping Y; Zhang Y; Liao J; Wang Y; Hou X; Jiang Z; Dong X; Xu C; Xiao Y
Cancer Med; 2020 Dec; 9(24):9485-9498. PubMed ID: 33078899
[TBL] [Abstract][Full Text] [Related]
9. Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer.
Zhang E; He J; Zhang H; Shan L; Wu H; Zhang M; Song Y
Front Genet; 2020; 11():595657. PubMed ID: 33281882
[TBL] [Abstract][Full Text] [Related]
10. Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis.
Xiong Z; Yang Q; Li X
CNS Neurosci Ther; 2020 Sep; 26(9):981-989. PubMed ID: 32488994
[TBL] [Abstract][Full Text] [Related]
11. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL.
Anand P; Guillaumet-Adkins A; Dimitrova V; Yun H; Drier Y; Sotudeh N; Rogers A; Ouseph MM; Nair M; Potdar S; Isenhart R; Kloeber JA; Vijaykumar T; Niu L; Vincent T; Guo G; Frede J; Harris MH; Place AE; Silverman LB; Teachey DT; Lane AA; DeAngelo DJ; Aster JC; Bernstein BE; Lohr JG; Knoechel B
Blood; 2021 May; 137(18):2463-2480. PubMed ID: 33227818
[TBL] [Abstract][Full Text] [Related]
13. Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy.
VanderWeele DJ; Finney R; Katayama K; Gillard M; Paner G; Imoto S; Yamaguchi R; Wheeler D; Lack J; Cam M; Pontier A; Nguyen YTM; Maejima K; Sasaki-Oku A; Nakano K; Tanaka H; Vander Griend D; Kubo M; Ratain MJ; Miyano S; Nakagawa H
Eur Urol Focus; 2019 May; 5(3):416-424. PubMed ID: 29398457
[TBL] [Abstract][Full Text] [Related]
14. In silico screening using bulk and single-cell RNA-seq data identifies RIMS2 as a prognostic marker in basal-like breast cancer: A retrospective study.
Zhang L; Liu Z; Zhu J
Medicine (Baltimore); 2021 Apr; 100(16):e25414. PubMed ID: 33879671
[TBL] [Abstract][Full Text] [Related]
15. The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression.
Espiritu SMG; Liu LY; Rubanova Y; Bhandari V; Holgersen EM; Szyca LM; Fox NS; Chua MLK; Yamaguchi TN; Heisler LE; Livingstone J; Wintersinger J; Yousif F; Lalonde E; Rouette A; Salcedo A; Houlahan KE; Li CH; Huang V; Fraser M; van der Kwast T; Morris QD; Bristow RG; Boutros PC
Cell; 2018 May; 173(4):1003-1013.e15. PubMed ID: 29681457
[TBL] [Abstract][Full Text] [Related]
16. Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer.
Rye MB; Bertilsson H; Drabløs F; Angelsen A; Bathen TF; Tessem MB
BMC Med Genomics; 2014 Aug; 7():50. PubMed ID: 25115192
[TBL] [Abstract][Full Text] [Related]
17. SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing.
Niknafs N; Beleva-Guthrie V; Naiman DQ; Karchin R
PLoS Comput Biol; 2015 Oct; 11(10):e1004416. PubMed ID: 26436540
[TBL] [Abstract][Full Text] [Related]
18. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
[TBL] [Abstract][Full Text] [Related]
19. Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma.
Geistlinger L; Oh S; Ramos M; Schiffer L; LaRue RS; Henzler CM; Munro SA; Daughters C; Nelson AC; Winterhoff BJ; Chang Z; Talukdar S; Shetty M; Mullany SA; Morgan M; Parmigiani G; Birrer MJ; Qin LX; Riester M; Starr TK; Waldron L
Cancer Res; 2020 Oct; 80(20):4335-4345. PubMed ID: 32747365
[TBL] [Abstract][Full Text] [Related]
20. Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.
Parisi F; Ariyan S; Narayan D; Bacchiocchi A; Hoyt K; Cheng E; Xu F; Li P; Halaban R; Kluger Y
BMC Genomics; 2011 May; 12():230. PubMed ID: 21569352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
